Managing Your Symptoms and Daily Life
At a Glance
Primary lateral sclerosis has no cure that stops progression, but individualized care can protect comfort and independence. Medicines, physical and occupational therapy, speech and swallowing support, communication tools, and safety planning help manage daily symptoms.
While there is currently no cure or therapy that stops the progression of Primary Lateral Sclerosis (PLS), the disease is highly manageable through targeted symptomatic care. Because PLS moves slowly, your care team has time to focus on preserving your quality of life, comfort, and independence [1][2]. This “symptomatic” approach means that while we cannot yet repair the motor neurons, we can effectively manage the effects of their failure.
Managing Muscle Stiffness (Spasticity)
The most common symptom of PLS is spasticity, or persistent muscle tightness. Management usually begins with oral medications and moves toward more specialized interventions if needed.
- Oral Medications: Baclofen and tizanidine are common treatments. It is critical to know that these can cause sedation, dizziness, hypotension (low blood pressure), and weakness. Baclofen must not be stopped abruptly because withdrawal can be dangerous; dosing and tapering require clinician supervision [3][4].
- Botulinum Toxin (Botox): For selected focal muscles, botulinum toxin can provide relief without whole-body side effects [5]. However, it can worsen weakness or swallowing, depending on the muscles treated.
- Intrathecal Baclofen Pump (ITB): If your stiffness is severe and not well-controlled by pills, your doctor may suggest a baclofen pump. This delivers medication directly into the fluid surrounding your spinal cord [6][7]. An intrathecal pump requires a screening trial and carries surgical, infection, catheter, overdose, and life-threatening withdrawal risks. Pump-maintenance and emergency guidance should be reviewed with your team [4][8].
The Role of PT and OT
Physical Therapy (PT) and Occupational Therapy (OT) are the cornerstones of PLS care. Patients with PLS may benefit from individualized aerobic activity, resistance or functional strengthening, stretching, and range-of-motion work [9][10].
- Preserving Mobility: PTs focus on gait and balance training to help you walk safely for as long as possible [9]. The goal is to avoid excessive fatigue, pain, falls, or delayed weakness. This includes a PT-supervised, symptom-guided exercise plan with clear advice to stop and report worsening symptoms [11].
- Preventing Contractures: Ongoing therapy focuses on stretching to prevent permanent joint tightness (contractures) [12].
- Daily Independence: OTs help you adapt your home and routines—like dressing or cooking—so you can continue them safely [2][10].
Supporting Speech and Swallowing
If your PLS affects your mouth and throat muscles (bulbar symptoms), a Speech-Language Pathologist (SLP) becomes a vital part of your team.
- Safe Swallowing: Head positioning and texture modification should not be portrayed as universally safe solutions you can try independently. These strategies must follow an individualized SLP assessment and instrumental testing; thickened liquids or restrictive diets can reduce hydration and nutrition. You should have prompt review for aspiration warning signs like recurrent coughing or choking, a wet or gurgly voice after swallowing, recurrent chest infections, or weight loss [13][1].
- Augmentative Communication: If speech becomes difficult, your team may introduce Augmentative and Alternative Communication (AAC), ranging from letter boards to high-tech devices [14].
Managing Secondary Symptoms
- Pseudobulbar Affect (PBA): Involuntary laughing or crying can sometimes be managed with dextromethorphan/quinidine (Nuedexta) or certain antidepressants [15][16]. However, evidence specifically in PLS is limited. Quinidine can prolong the QT interval and interact with other medicines, including some antidepressants. Antidepressants are generally an individualized off-label option; patients should not start either approach without a prescriber’s cardiac and medication review [17].
- Bladder Urgency: Many people experience urinary urgency or frequency [3]. However, significant sphincter symptoms can be a diagnostic red flag, and UTI, retention, medication effects, and spinal disease should be considered before attributing them to PLS.
- Pain: Managing the stiffness effectively is usually the first step in managing joint and muscle pain [18][3].
Common questions in this guide
How can muscle stiffness from PLS be treated?
What should I know before considering a baclofen pump for PLS?
What exercise is recommended for people with primary lateral sclerosis?
How should swallowing changes in PLS be evaluated?
What can help when PLS makes speech difficult?
How is uncontrollable laughing or crying treated in PLS?
Could urinary urgency in PLS have another cause?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on Primary lateral sclerosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How much oral baclofen is too much before we should discuss a baclofen pump?
- 2.Which specific muscles are most affected by my spasticity, and would botulinum toxin (Botox) injections be a helpful addition?
- 3.Can we set an individualized exercise program that balances aerobic, resistance, and stretching work safely?
- 4.What are the signs that I should transition from a cane to a walker or wheelchair to prevent falls?
- 5.Could my urinary symptoms be related to medications, a UTI, or a spinal issue rather than PLS directly?
- 6.What is the plan for my communication—when should I start looking at speech-generating devices?
References
References (18)
- 1
Primary Lateral Sclerosis French National Diagnostic and Care Protocol.
Corcia P, Bernard E, de la Cruz E, et al.
Revue neurologique 2026; (182(6)):555-562 doi:10.1016/j.neurol.2026.04.006.
PMID: 42168009 - 2
Clinical care and therapeutic trials in PLS.
Floeter MK, Warden D, Lange D, et al.
Amyotrophic lateral sclerosis & frontotemporal degeneration 2020; (21(sup1)):67-73 doi:10.1080/21678421.2020.1837180.
PMID: 33602017 - 3
Demographics and clinical characteristics of primary lateral sclerosis: case series and a review of literature.
Ramanathan RS, Rana S
Neurodegenerative disease management 2018; (8(1)):17-23 doi:10.2217/nmt-2017-0051.
PMID: 29316850 - 4
Efficacy and safety of oral baclofen in the management of spasticity: A rationale for intrathecal baclofen.
Ertzgaard P, Campo C, Calabrese A
Journal of rehabilitation medicine 2017; (49(3)):193-203 doi:10.2340/16501977-2211.
PMID: 28233010 - 5
Safety and efficacy of botulinum toxin A for the treatment of spasticity in amyotrophic lateral sclerosis: results of a pilot study.
Vázquez-Costa JF, Máñez I, Alabajos A, et al.
Journal of neurology 2016; (263(10)):1954-60 doi:10.1007/s00415-016-8223-z.
PMID: 27383643 - 6
European expert consensus on improving patient selection for the management of disabling spasticity with intrathecal baclofen and/or botulinum toxin type A.
Biering-Soerensen B, Stevenson V, Bensmail D, et al.
Journal of rehabilitation medicine 2022; (54()):jrm00241 doi:10.2340/16501977-2877.
PMID: 34608495 - 7
Utility of intrathecal baclofen pump in primary lateral sclerosis.
Zubair AS, Raymond M, Patwa HS
Journal of the neurological sciences 2021; (420()):117227 doi:10.1016/j.jns.2020.117227.
PMID: 33239209 - 8
Intrathecal Baclofen to Improve Functional Status in ALS: A Case Report.
Pressler MP, Cooper PS, Carter W, et al.
Pain medicine case reports 2023; (7(4)):201-203.
PMID: 40957031 - 9
Rehabilitation in primary lateral sclerosis mimicking parkinsonism: A case report.
Moggio L, Petraroli A, Marotta N, et al.
NeuroRehabilitation 2020; (47(4)):381-386 doi:10.3233/NRE-201527.
PMID: 33164952 - 10
A Case Report on Robot-Aided Gait Training in Primary Lateral Sclerosis Rehabilitation: Rationale, Feasibility and Potential Effectiveness of a Novel Rehabilitation Approach.
Portaro S, Ciatto L, Raciti L, et al.
Innovations in clinical neuroscience 2021; (18(4-6)):15-19.
PMID: 34980978 - 11
Evolving diagnostic criteria in primary lateral sclerosis: The clinical and radiological basis of "probable PLS".
Finegan E, Li Hi Shing S, Siah WF, et al.
Journal of the neurological sciences 2020; (417()):117052 doi:10.1016/j.jns.2020.117052.
PMID: 32731060 - 12
Best Practices for Intrathecal Baclofen Therapy: Patient Selection.
Saulino M, Ivanhoe CB, McGuire JR, et al.
Neuromodulation : journal of the International Neuromodulation Society 2016; (19(6)):607-15 doi:10.1111/ner.12447.
PMID: 27434197 - 13
Primary lateral sclerosis: diagnosis and management.
Turner MR, Talbot K
Practical neurology 2020; (20(4)):262-269 doi:10.1136/practneurol-2019-002300.
PMID: 32217663 - 14
Effects of Aided Communication on Communicative Participation for People With Amyotrophic Lateral Sclerosis.
Peters B, Wiedrick J, Baylor C
American journal of speech-language pathology 2023; (32(4)):1450-1465 doi:10.1044/2023_AJSLP-22-00346.
PMID: 37335771 - 15
Efficacy and safety of dextromethorphan/quinidine in treating pseudobulbar affect in neurological disorders: A systematic review and dose-classified network meta-analysis.
Muneer MA, Tariq I, Zulfiqar E, et al.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2026; (47(1)):159.
PMID: 41530593 - 16
Effect of one-year dextromethorphan/quinidine treatment on management of respiratory impairment in amyotrophic lateral sclerosis.
Sancho J, Ferrer S, Burés E, et al.
Respiratory medicine 2021; (186()):106536 doi:10.1016/j.rmed.2021.106536.
PMID: 34260979 - 17
Pathological laughter and crying in neurological disorders: recognition and treatment.
Husbands E, Talbot K
Practical neurology 2022; (22(6)):486-490 doi:10.1136/pn-2021-003301.
PMID: 35907635 - 18
Non-motor symptoms in motor neuron disease: prevalence, assessment and impact.
Beswick E, Forbes D, Johnson M, et al.
Brain communications 2024; (6(1)):fcad336 doi:10.1093/braincomms/fcad336.
PMID: 38162906
This page is for informational purposes only and does not constitute medical advice. For primary lateral sclerosis, work with your clinician before changing medicines, exercise, swallowing strategies, or communication and mobility equipment.